These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 21719102)
1. The use of the fusion protein RGD-HSA-TIMP2 as a tumor targeting imaging probe for SPECT and PET. Choi N; Kim SM; Hong KS; Cho G; Cho JH; Lee C; Ryu EK Biomaterials; 2011 Oct; 32(29):7151-8. PubMed ID: 21719102 [TBL] [Abstract][Full Text] [Related]
2. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5). Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851 [TBL] [Abstract][Full Text] [Related]
3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
4. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis. Dumont RA; Deininger F; Haubner R; Maecke HR; Weber WA; Fani M J Nucl Med; 2011 Aug; 52(8):1276-84. PubMed ID: 21764795 [TBL] [Abstract][Full Text] [Related]
5. RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis. Lee J; Lee TS; Ryu J; Hong S; Kang M; Im K; Kang JH; Lim SM; Park S; Song R J Nucl Med; 2013 Jan; 54(1):96-103. PubMed ID: 23232276 [TBL] [Abstract][Full Text] [Related]
6. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors. Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983 [TBL] [Abstract][Full Text] [Related]
7. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody. Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007 [TBL] [Abstract][Full Text] [Related]
8. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379 [TBL] [Abstract][Full Text] [Related]
9. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975 [TBL] [Abstract][Full Text] [Related]
11. A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression. Cai W; Zhang X; Wu Y; Chen X J Nucl Med; 2006 Jul; 47(7):1172-80. PubMed ID: 16818952 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro and in vivo evaluation of SiFA-tagged bombesin and RGD peptides as tumor imaging probes for positron emission tomography. Lindner S; Michler C; Leidner S; Rensch C; Wängler C; Schirrmacher R; Bartenstein P; Wängler B Bioconjug Chem; 2014 Apr; 25(4):738-49. PubMed ID: 24666287 [TBL] [Abstract][Full Text] [Related]
13. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄. Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783 [TBL] [Abstract][Full Text] [Related]
14. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815 [TBL] [Abstract][Full Text] [Related]
15. Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody. van Rij CM; Sharkey RM; Goldenberg DM; Frielink C; Molkenboer JD; Franssen GM; van Weerden WM; Oyen WJ; Boerman OC J Nucl Med; 2011 Oct; 52(10):1601-7. PubMed ID: 21865288 [TBL] [Abstract][Full Text] [Related]
16. Study on biodistribution and imaging of radioiodinated arginine-arginine-leucine peptide in nude mice bearing human prostate carcinoma. Yu M; Zhou H; Liu X; Huo Y; Zhu Y; Chen Y Ann Nucl Med; 2010 Jan; 24(1):13-9. PubMed ID: 19997991 [TBL] [Abstract][Full Text] [Related]
17. (18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors. Ma Y; Liang S; Guo J; Guo R; Wang H J Labelled Comp Radiopharm; 2014 Sep; 57(11):627-31. PubMed ID: 25294311 [TBL] [Abstract][Full Text] [Related]
18. Radiogallium Complex-Conjugated Bifunctional Peptides for Detecting Primary Cancer and Bone Metastases Simultaneously. Ogawa K; Yu J; Ishizaki A; Yokokawa M; Kitamura M; Kitamura Y; Shiba K; Odani A Bioconjug Chem; 2015 Aug; 26(8):1561-70. PubMed ID: 26087328 [TBL] [Abstract][Full Text] [Related]
19. [Tumor targeting efficacy of a novel PET radiotracer (1)8F-AlF-NOTA-PRGD2 in mice]. Wu H; Wang Q; Han Y; Zhou W; Li H; Tian Y; Wang Q Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):51-5. PubMed ID: 24463116 [TBL] [Abstract][Full Text] [Related]
20. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Liu S Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]